1.
Malnique F, Queiroz GD, da Silva DGR, et al. COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT. Editora. Published online November 10, 2025:316-330. Accessed January 10, 2026. https://sevenpubl.com.br/editora/article/view/8436